Psychosis Associated With Alzheimer's Disease Clinical Trials
2 recruiting trials for Psychosis Associated With Alzheimer's Disease. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT05511363
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease...
This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyEnrolling: 41020 locations
RECRUITINGPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
ML-007C-MA-221 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ML-007C-MA in male and female participants aged 55 to 90...
Sponsor: MapLight TherapeuticsEnrolling: 30020 locations